General Information of the Compound
Compound ID |
CP0548320
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
9-(azetidin-3-ylamino)-1-cyclopropyl-3,5-dihydro-1H-[1,2,4]triazino[3,4-c][1,4]benzoxazin-2-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H19N5O2
|
||||||||||||||||||
Molecular Weight |
313.361
|
||||||||||||||||||
Canonical SMILES |
O=C1NN=C2COc3ccc(NC4CNC4)cc3N2C1C1CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H19N5O2/c22-16-15(9-1-2-9)21-12-5-10(18-11-6-17-7-11)3-4-13(12)23-8-14(21)19-20-16/h3-5,9,11,15,17-18H,1-2,6-8H2,(H,20,22)
Show/Hide
|
||||||||||||||||||
InChIKey |
PFJUOWVMQUAMDQ-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00858, Protein kinase C alpha type
Protein ID: PT01127, Protein kinase C theta type